Provided by Tiger Trade Technology Pte. Ltd.

Erasca, Inc.

17.63
+0.55003.22%
Post-market: 17.640.0100+0.06%19:48 EDT
Volume:2.45M
Turnover:43.10M
Market Cap:6.17B
PE:-18.16
High:17.84
Open:17.28
Low:17.21
Close:17.08
52wk High:24.28
52wk Low:1.33
Shares:349.76M
Float Shares:291.15M
Volume Ratio:0.97
T/O Rate:0.84%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9710
EPS(LYR):-0.4393
ROE:-78.25%
ROA:-21.39%
PB:17.04
PE(LYR):-40.14

Loading ...

Erasca Confronts Trial Fatality And Lawsuit As Valuation Debate Deepens

Simply Wall St.
·
May 03

Stock Track | Erasca Soars 8.78% Intraday on Positive Clinical Trial Updates and Corporate Pipeline Presentation

Stock Track
·
Apr 30

Erasca publishes corporate presentation on RAS/MAPK cancer drug pipeline

Reuters
·
Apr 30

Stock Track | Erasca, Inc. Plummets 5.05% in Pre-Market on Clinical Trial Safety Concerns and Patent Litigation

Stock Track
·
Apr 29

Clinical Trial Fatality Raises Safety Concerns: Cancer Drug Developer Erasca (ERAS.US) Shares Halved in Single-Day 48% Plunge

Stock News
·
Apr 29

Erasca announces annual shareholder meeting webcast

Reuters
·
Apr 29

Small U.S. Stocks Decrease; Erasca Posts Biggest Loss

Dow Jones
·
Apr 29

Erasca Shares Crater After Cancer Trial Update Reveals Patient Death -- WSJ

Dow Jones
·
Apr 29

Erasca Shares Fall After Preliminary Phase 1 Dose Escalation Data

MT Newswires Live
·
Apr 29

H.C. Wainwright sees pressure for Erasca shares pending safety visibility

TIPRANKS
·
Apr 29

Erasca Stock Sinks 50% in Race for 'Miracle' Cancer Drug. What's Behind the Historic Sell-Off. -- Barrons.com

Dow Jones
·
Apr 29

BUZZ-U.S. STOCKS ON THE MOVE-Enterprise Products, Sherwin-Williams, Veradermics

Reuters
·
Apr 28

Erasca falls -46.0%

TIPRANKS
·
Apr 28

Erasca Down Over 50%, On Pace for Record Percent Decrease -- Data Talk

Dow Jones
·
Apr 28

Erasca Shares Down 46.4% After Patient Death in Early-Stage Cancer Drug Trial

THOMSON REUTERS
·
Apr 28

Erasca falls after disclosing patient died after withdrawing from trial

TIPRANKS
·
Apr 28

Top Premarket Decliners

MT Newswires Live
·
Apr 28

BUZZ-U.S. STOCKS ON THE MOVE-UPS, Centene, Coca-Cola

Reuters
·
Apr 28

Analyst Maintains Buy on ERAS-0015’s Promising Early Data, Keeps Price Target Unchanged at $20

TIPRANKS
·
Apr 28

BUZZ-Erasca drops after patient death reported in early cancer trial

Reuters
·
Apr 28